Literature DB >> 9032900

Murine cytomegalovirus inactivated by sodium periodate is innocuous and immunogenic in mice and protects them against death and infection.

F Geoffroy1, N Moachon, J Rodwell, G A Quash.   

Abstract

Sodium periodate (10 mM, 4 degrees C) inactivated murine cytomegalovirus (MCMV) very rapidly (loss of 2 to 3 log of viral infectivity per minute). Periodate-treated MCMV (PI-MCMV) was shown to be innocuous in mice, as determined by the inability of the virus to replicate. PI-MCMV induced a strong humoral immune response, with a high level of neutralizing antibodies. Mice immunized with PI-MCMV were protected against death and infection, when a lethal challenge with the virulent virus was administered 3 weeks after immunization and from death but not infection when virulent virus was administered at 3 months. Finally, no reactivation of potentially latent challenge virus (sublethal dose at 3 weeks) was observed in animals immunosuppressed at 6 months after immunization. Taken together, these results suggest that periodate could serve as an inactivating agent to prepare killed vaccines.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9032900     DOI: 10.1016/s0264-410x(96)00116-8

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  7 in total

1.  Development of a vaccine against murine cytomegalovirus (MCMV), consisting of plasmid DNA and formalin-inactivated MCMV, that provides long-term, complete protection against viral replication.

Authors:  Christopher S Morello; Ming Ye; Deborah H Spector
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

2.  Immunization with cytomegalovirus envelope glycoprotein M and glycoprotein N DNA vaccines can provide mice with complete protection against a lethal murine cytomegalovirus challenge.

Authors:  Huadong Wang; Yanfeng Yao; Chaoyang Huang; Quanjiao Chen; Jianjun Chen; Ze Chen
Journal:  Virol Sin       Date:  2013-05-24       Impact factor: 4.327

Review 3.  MHC class I immune evasion in MCMV infection.

Authors:  Carmen M Doom; Ann B Hill
Journal:  Med Microbiol Immunol       Date:  2008-03-11       Impact factor: 3.402

4.  A caprine herpesvirus 1 vaccine adjuvanted with MF59™ protects against vaginal infection and interferes with the establishment of latency in goats.

Authors:  Mariarosaria Marinaro; Giovanni Rezza; Giuseppe Del Giudice; Valeriana Colao; Elvira Tarsitano; Michele Camero; Michele Losurdo; Canio Buonavoglia; Maria Tempesta
Journal:  PLoS One       Date:  2012-04-12       Impact factor: 3.240

5.  Complete protection of mice against lethal murine cytomegalovirus challenge by immunization with DNA vaccines encoding envelope glycoprotein complex III antigens gH, gL and gO.

Authors:  Huadong Wang; Chaoyang Huang; Jinrong Dong; Yanfeng Yao; Zhenyuan Xie; Xueying Liu; Wenjie Zhang; Fang Fang; Ze Chen
Journal:  PLoS One       Date:  2015-03-24       Impact factor: 3.240

6.  Virion glycosylation governs integrity and infectivity of infectious pancreatic necrosis virus.

Authors:  H Fridholm; E Everitt
Journal:  J Fish Dis       Date:  2011-09       Impact factor: 2.767

7.  An adjuvanted inactivated murine cytomegalovirus (MCMV) vaccine induces potent and long-term protective immunity against a lethal challenge with virulent MCMV.

Authors:  Huadong Wang; Yanfeng Yao; Chaoyang Huang; Xingxing Fu; Quanjiao Chen; Hongbo Zhang; Jianjun Chen; Fang Fang; Zhenyuan Xie; Ze Chen
Journal:  BMC Infect Dis       Date:  2014-04-11       Impact factor: 3.090

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.